Pregabalin overdose causing sinus bradycardia – A rare complication

Main Article Content

Rajesh Kumar*
Jathinder Kumar
Ihtisham Malik
Gordon Pate

Abstract

We present the unique case of severe, symptomatic bradycardia associated with pregabalin overdose. Pregabalin is a widely prescribed drug not routinely associated with sinus bradycardia. A 39 year old male, presented having taken about 4g of pregablin with intention to self-harm. Following admission, he subsequently developed bradycardia on telemetry. Other possible causes were excluded with serial investigations. The bradycardia resolved by 96 hours without the need for temporary pacing. Patients presenting with pregabalin overdose should be monitored for bradycardia.

Downloads

Download data is not yet available.

Article Details

Kumar, R., Kumar, J., Malik, I., & Pate, G. (2021). Pregabalin overdose causing sinus bradycardia – A rare complication. Journal of Cardiovascular Medicine and Cardiology, 8(1), 007–009. https://doi.org/10.17352/2455-2976.000160
Case Reports

Copyright (c) 2021 Kumar R, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45: 13-18. Link: https://bit.ly/3tWUIbA

Evoy KE, Morrison MD, Saklad SR (2017) Abuse and Misuse of Pregabalin and Gabapentin. Drugs 77: 403-426. Link: https://bit.ly/2Z9SXdc

Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ, et al. (2018) Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015. Clin Drug Investig 38: 373-380. Link: https://bit.ly/3qurleZ

Page RL, Cantu M, Lindenfeld J, Hergott LJ, Lowes BD (2008) Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. J Cardiovasc Med (Hagerstown) 9: 922-925. Link: https://bit.ly/3pg4m5P

Pregabalin: cardiac adverse effects (2014) Prescrire Int 23: 45.Link: https://bit.ly/3jIGV3Z

Aksakal E, Bakirci EM, Emet M, Uzkeser M (2012) Complete atrioventricular block due to overdose of pregabalin. Am J Emerg Med 30: 2101.e1–2101.e21014. Link: https://bit.ly/3tXwhLw

Schiavo A, Stagnaro FM, Salzano A, Marra AM, Bobbio E, et al. (2017) Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis. Monaldi Arch Chest Dis 87: 838. https://bit.ly/3aVUOru

Pfizer Australia Pty Ltd (2005) lyrica( pregabalin), ABN 50 008 422 348 38 – 42 edn., Wharf Road West Ryde NSW 2114:pfizer.

Pexton T, Moeller-Bertram T, Schilling JM, Wallace MS (2011) Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs 20: 1277-1284. Link: https://bit.ly/379Xdha

Ono K, Iijima T (2010) Cardiac T-type Ca(2+) channels in the heart. J Mol Cell Cardiol 48: 65-70. Link: https://bit.ly/2LKOv1i